Drug Formulation and Analytical News
March 2, 2012
Rubicon Genomics chooses Velesco to manufacture its Transplex RNA Amplification kits.
Feb 15, 2012
Velesco is featured in an article about companies that have sprung out of and flourished after Pfizer's exit from Ann Arbor, MI.
April 28, 2011
COO Gerry Cox is featured in a Fortune Magazine article.
Velesco Pharmaceutical Services expands core scientific and quality team.
Dave Barnes, CEO of Velesco Pharmaceutical Services, is the subject of an editorial: "Stage Two Strategies" in Crain's Detroit Business.
April 14, 2010
Velesco Pharmaceutical Services receives a "Catalyst Award" for 2009 economic growth, and is recognized as a 2010 "Michigan 50 Companies to Watch" recipient.
Velesco Pharmaceutical Services joins BIOCOM, the Southern California Life Science Association.
June 9, 2009
Velesco Pharmaceutical Services opens new Clinical Trial Materials cGMP production facility and moves to expanded laboratory space.
Velesco's new Laboratory Address: 46701 N. Commerce Center Dr, Suite A8, Plymouth, MI 48170.
April 7, 2009
Velesco's participation in the upcoming Michigan CMC Alliance featured on outsourcing-pharma.com.
February 6, 2009
Velesco Pharmaceutical Services Expands Core Scientific Team
Velesco supported the Ann Arbor Youth Chorale for their 22nd Annual Winter Concert.
November 12, 2008
Velesco Pharmaceutical Services plans to double staff in Ann Arbor.
Click here to read full article
September 23, 2008
SCORR Marketing Chosen as Agency of Record for Velesco Pharmaceutical Services
Click here for the Press Release
August 15, 2008
Velesco Pharmaceutical Services has joined the Massachusetts Biotechnology Council.
For more details, view the Massachusetts Biotechnology Council Website.
July 17, 2008
Gerry Cox, Velesco's chief operating officer is profiled in the Ann Arbor Business Review. Click here to read full article
June 2, 2008
Velesco Pharmaceutical Services has relocated into a new, purpose built laboratory building in Ann Arbor, Michigan. This facility provides the necessary wet lab space with associated ancillary areas to support Velesco's near term growth plans.
The laboratories were refurbished and briefly occupied by Pfizer and are state-of-the-art for analytical chemistry and formulation science.